These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17318630)

  • 1. Using dimension reduction to improve outbreak predictability of multistrain diseases.
    Shaw LB; Billings L; Schwartz IB
    J Math Biol; 2007 Jul; 55(1):1-19. PubMed ID: 17318630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chaotic desynchronization of multistrain diseases.
    Schwartz IB; Shaw LB; Cummings DA; Billings L; McCrary M; Burke DS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 2):066201. PubMed ID: 16486034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemics with multistrain interactions: the interplay between cross immunity and antibody-dependent enhancement.
    Bianco S; Shaw LB; Schwartz IB
    Chaos; 2009 Dec; 19(4):043123. PubMed ID: 20059219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological serotype interactions and their effect on the epidemiological pattern of dengue.
    Recker M; Blyuss KB; Simmons CP; Hien TT; Wills B; Farrar J; Gupta S
    Proc Biol Sci; 2009 Jul; 276(1667):2541-8. PubMed ID: 19369266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinations in disease models with antibody-dependent enhancement.
    Billings L; Fiorillo A; Schwartz IB
    Math Biosci; 2008 Feb; 211(2):265-81. PubMed ID: 17923138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Framework for Inferring Unobserved Multistrain Epidemic Subpopulations Using Synchronization Dynamics.
    Forgoston E; Shaw LB; Schwartz IB
    Bull Math Biol; 2015 Jul; 77(7):1437-55. PubMed ID: 26251155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever.
    Hu K; Thoens C; Bianco S; Edlund S; Davis M; Douglas J; Kaufman JH
    J Theor Biol; 2013 Feb; 319():62-74. PubMed ID: 23206388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instabilities in multiserotype disease models with antibody-dependent enhancement.
    Billings L; Schwartz IB; Shaw LB; McCrary M; Burke DS; Cummings DA
    J Theor Biol; 2007 May; 246(1):18-27. PubMed ID: 17270219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
    de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
    PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of different serotypes of dengue virus.
    Esteva L; Vargas C
    J Math Biol; 2003 Jan; 46(1):31-47. PubMed ID: 12525934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of an asymmetric two-strain dengue model.
    Kooi BW; Aguiar M; Stollenwerk N
    Math Biosci; 2014 Feb; 248():128-39. PubMed ID: 24434818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecological and immunological determinants of dengue epidemics.
    Wearing HJ; Rohani P
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11802-7. PubMed ID: 16868086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
    Lisova O; Belkadi L; Bedouelle H
    J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.
    Kribs C; Greenhalgh D
    J Math Biol; 2023 Apr; 86(5):85. PubMed ID: 37119296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary Cross-Immunity as a Plausible Driver of Asynchronous Cycles of Dengue Serotypes.
    Fung T; Clapham HE; Chisholm RA
    Bull Math Biol; 2023 Nov; 85(12):124. PubMed ID: 37962713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.
    Ferguson N; Anderson R; Gupta S
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):790-4. PubMed ID: 9892712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains.
    Kawaguchi I; Sasaki A; Boots M
    Proc Biol Sci; 2003 Nov; 270(1530):2241-7. PubMed ID: 14613610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.